S100B, S100 calcium binding protein B, 6285

N. diseases: 599; N. variants: 6
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0278134
Disease: Absence of sensation
Absence of sensation
0.020 Biomarker phenotype BEFREE <b>Aim:</b> To clarify the impact of general anaesthesia on cognitive function and to study the possible effect of general anaesthesia on serum S100B, the marker of neuronal degeneration. 30590973 2019
CUI: C0233794
Disease: Memory impairment
Memory impairment
0.030 Biomarker phenotype BEFREE <b>Conclusion:</b> General anaesthesia is incriminated in the development of postoperative verbal and visual memory impairment and in the postoperative increase in serum S100B, the markers of neuronal degeneration. 30590973 2019
CUI: C0542476
Disease: Forgetful
Forgetful
0.020 Biomarker phenotype BEFREE <b>Conclusion:</b> General anaesthesia is incriminated in the development of postoperative verbal and visual memory impairment and in the postoperative increase in serum S100B, the markers of neuronal degeneration. 30590973 2019
CUI: C0014544
Disease: Epilepsy
Epilepsy
0.220 AlteredExpression disease BEFREE <b>Main outcomes and measures:</b> Peripheral blood levels of S100B in patients with epilepsy compared with controls. 31156363 2019
CUI: C0023364
Disease: Leptospirosis
Leptospirosis
0.010 AlteredExpression disease BEFREE <b>Results:</b> The control group differed significantly from the leptospirosis and septic shock patients which demonstrate strong similarities: diffuse congestion in the red pulp with a moderate to intense infiltration of plasma cells and polymorphonuclear cells; follicles with marked atrophy; high density of CD20<sup>+</sup> cells; low density of NK, TCD4<sup>+</sup> and active caspase-3 positive cells and strong expression of IL-10; leptospirosis patients had higher S100 and TNF-α positive cells in the spleen than the other groups. 31114579 2019
CUI: C0023343
Disease: Leprosy
Leprosy
0.010 Biomarker disease BEFREE (i) In demonstrating neural granuloma, sensitivity of H and E was 48.27% and that of S100 was 100%, (ii) Morphology of nerve fragments on S100 stain for cases of leprosy was fragmented and infiltrated in 37, intact and infiltrated in 19, reduced, fragmented, and infiltrated in seven, and absent in one, (iii) There was a significant difference (<i>P</i> <0.001) in the pattern of staining of S100 on intact nerve and nerves involved by granuloma in leprosy, and (iv) The probability to differentiate between leprosy and nonleprosy granuloma was statistically significant (<i>P</i> <0.001). 29937557 2019
Human immunodeficiency virus (HIV) II infection category B1
0.100 Biomarker disease BEFREE Human immunodeficiency virus type 1 Nef protein mediates neural cell death: a neurotoxic role for IP-10. 15518810 2004
CUI: C1709246
Disease: Non-Neoplastic Disorder
Non-Neoplastic Disorder
0.010 AlteredExpression disease BEFREE Non-neoplastic glands also frequently expressed S100 A2 diminishing its potential diagnostic utility. 18223320 2008
CUI: C0206651
Disease: Clear Cell Sarcoma of Soft Tissue
Clear Cell Sarcoma of Soft Tissue
0.030 Biomarker disease BEFREE Clear cell sarcomas and melanomas were also examined for their immunoreactivity to S-100 protein and HMB-45 antigen. 2004337 1991
Histiocytosis with joint contractures and sensorineural deafness
0.030 AlteredExpression disease BEFREE SHML cells expressed the following: (1) S-100 protein, (2) "pan-macrophage" antigens such as EBM11, HAM 56, and Leu-M3, (3) antigens functionally associated with phagocytosis (Fc receptor for IgG, complement receptor 3), and lysosomal activity (lysozyme, alpha 1-antichymotrypsin, and alpha 1-antitrypsyn), (4) antigens associated with early inflammation (Mac-387, 27E10), (5) antigens commonly found on monocytes, but not tissue macrophages (OKM5, Leu-M1), and (6) "activation" antigens (Ki-1 and receptors for transferrin and interleukin 2). 2180014 1990
Secondary malignant neoplasm of liver
0.020 AlteredExpression disease BEFREE Liver metastasis was significantly correlated with overexpression of S100B (p=0.001, OR=9.217), TM4SF3 (p=0.011, OR=4.385), and OLFM4 (p=0.015, OR=3.438). 22011044 2012
CUI: C0085750
Disease: Adenosis of Breast
Adenosis of Breast
0.020 Biomarker disease BEFREE Microglandular adenosis (MGA) is a rare proliferative lesion of the breast composed of small glands lacking myoepithelial cells and lined by S100-positive, oestrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative epithelial cells. 26806567 2016
Human immunodeficiency virus (HIV) II infection category B1
0.100 GeneticVariation disease BEFREE Human Immunodeficiency Virus-1 (HIV-1) encodes a 27 kDa Negative Factor or Nef protein, which is increasingly proving to be a misnomer. 26915805 2016
Human immunodeficiency virus (HIV) II infection category B1
0.100 Biomarker disease BEFREE Human immunodeficiency virus (HIV)-negative factor (Nef) protein is an accessory pathogenic factor, which plays a significant role in acquired immune deficiency syndrome (AIDS). 27981421 2017
CUI: C2825741
Disease: Indeterminate dendritic cell tumor
Indeterminate dendritic cell tumor
0.020 Biomarker disease BEFREE Indeterminate dendritic cell tumor (IDCT) is a proliferation of CD1a+, S100+ and langerin- histiocytes with a generally benign course. 28966519 2017
CUI: C1275959
Disease: Cellular neurothekeoma
Cellular neurothekeoma
0.010 Biomarker disease BEFREE Cellular neurothekeoma (CNT) is a dermal lesion with still unknown histogenesis, characterized by immunohistochemical staining for NKI/C3, NSE, MiTF, CD10 and CD68, whereas S100 protein, desmin and cytokeratins are negative. 30311258 2019
CUI: C0019625
Disease: Sinus histiocytosis
Sinus histiocytosis
0.070 AlteredExpression disease BEFREE Rosai-Dorfman disease (RDD) is an enigmatic histiocytic disorder classically diagnosed by a distinctive combination of pathological features: emperipolesis, or migration of intact haematological cells through the voluminous cytoplasm of lesional histiocytes, and expression of S100 by these histiocytes. 31172509 2019
CUI: C0019625
Disease: Sinus histiocytosis
Sinus histiocytosis
0.070 Biomarker disease BEFREE Rosai-Dorfman disease (RDD) is a rare entity characterized by proliferating S100-positive histiocytes. 31368911 2019
CUI: C0019625
Disease: Sinus histiocytosis
Sinus histiocytosis
0.070 Biomarker disease BEFREE Rosai-Dorfman disease (RDD) is an uncommon disorder, characterized by an atypical expansion of histiocytes which classically shows emperipolesis and immunoreactivity with S-100 protein. 31436555 2019
CUI: C0001127
Disease: Acidosis, Respiratory
Acidosis, Respiratory
0.010 Biomarker phenotype BEFREE Respiratory acidosis is associated to high concentrations of S100B protein in umbilical cord blood at birth. 31473201 2019
CUI: C0002395
Disease: Alzheimer's Disease
Alzheimer's Disease
0.300 AlteredExpression disease BEFREE S100beta overexpression in Alzheimer's disease correlates with the proliferation of betaAPP-immunoreactive neurites in beta-amyloid plaques. 10617132 2000
CUI: C0013080
Disease: Down Syndrome
Down Syndrome
0.400 Biomarker disease BEFREE S-100 beta, a gene triplicated in Down Syndrome (DS), is thought to play a role in development of the brain in general, and in the serotonergic neuronal system in particular. 12742260 2003
CUI: C4521042
Disease: Complete Trisomy 21 Syndrome
Complete Trisomy 21 Syndrome
0.100 Biomarker disease BEFREE S-100 beta, a gene triplicated in Down Syndrome (DS), is thought to play a role in development of the brain in general, and in the serotonergic neuronal system in particular. 12742260 2003
CUI: C0025202
Disease: melanoma
melanoma
0.100 Biomarker disease BEFREE S100 calcium-binding proteins such as S100B are elevated in primary malignant melanoma and are used as markers for this and numerous other cancers. 15178678 2004
CUI: C0021051
Disease: Immunologic Deficiency Syndromes
Immunologic Deficiency Syndromes
0.100 Biomarker group BEFREE Nef proteins from simian immunodeficiency virus-infected chimpanzees interact with p21-activated kinase 2 and modulate cell surface expression of various human receptors. 15194762 2004